An observational study in Ischemic Heart Disease, Cerebrovascular Disorders and Peripheral Arterial Disease, sponsored by Heart Care Foundation. Recruiting at 196 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-23.
Sponsored by Heart Care Foundation · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 87 studies in Myocardial Ischemia with a site in Italy — 15 open to participants now, 25 under way, none of them phase 3. Myocardial Ischemia · Italy.
Among the 87 studies in Myocardial Ischemia with a site in Italy, this one is the 2nd largest by planned enrollment of the 37 observational ones that give a count, is one of 4 that started in 2023, is one of 37 observational ones, reaches primary completion later than 7 of the 24 other live ones, and was the 73rd registered.
1,123 studies on the registry are indexed under Myocardial Ischemia; 177 are open to participants now.
Browse Myocardial Ischemia studies →15 of the 87 studies in Myocardial Ischemia with a site in Italy are open now. Recruiting first, the newest first:
IRCCS San Raffaele · Sites in Italy
Ages 18+
Fondazione Ricerca e Innovazione Cardiovascolare ETS · Sites in Italy
IRCCS Policlinico S. Donato · Sites in Italy
Ages 16+ · Healthy volunteers
Federico II University · Sites in Italy
IRCCS Policlinico S. Donato · Sites in Italy
Ages 6+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 135 Myocardial Ischemia studies recruiting now, 92 (68%) set no upper age limit and 6 (4%) stop at 75 or younger; 14 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
87 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 9 · Phase 3 8 · Phase 4 13
First in 2002; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 6,000 is above the median of 318 across 398 observational studies indexed under Myocardial Ischemia.
Median enrollment 418 across the 49 interventional studies, 509 across the 37 observational. Of the 45 that completed or were terminated, 6 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
26 of 87 have an industry lead sponsor. The 10 most frequent:
Heart Care Foundation is the lead sponsor of 22 studies on the registry; 6 are open to participants now.
Heart Care Foundation has 2 studies filed under Myocardial Ischemia — fewer than ten, so there is no comparison to draw.
7 of the studies in Myocardial Ischemia with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04604782GE HealthcareA Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients | 2026-12 |
| NCT06309511Istituto Auxologico ItalianoSubendocardial Viability Ratio in Hypertension | 2026-12-31 |
| NCT05027984Centro per la Lotta Contro l'Infarto - Fondazione OnlusInterventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS | 2027-01-31 |
| NCT07095634IRCCS Policlinico S. DonatoEstimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI) | 2027-02 |
| NCT06705751IRCCS Policlinico S. DonatoSpeed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta | 2027-02 |
Add all 7 to your calendar (.ics) → With an account.
Among the 87 studies in Myocardial Ischemia with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD):
Observational, prospective, multicenter study conducted in a large, representative sample of Italian cardiology centers.
Phases:
Patients discharged (after ordinary hospitalisation or day hospital) or managed as outpatients with a documented prior athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
At least one of the following clinical conditions:
Documented CAD defined as:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adherence to guideline for cholesterol level
Rate of patients at goal for LDL cholesterol (\<55 mg/dL)
Time frame: 6 months
Adherence to guideline for other risk factors
Rate of patients at goal for BP (SBP/DBP \< 130/80 mmHg) and at goal for HbA1c (\<7%) as well as rate of overweight patients (BMI \> 27 kg/m2) who show a weight loss of at least 10%
Time frame: 6 months
Patients' outcome
Rate of occurrence of clinical events (all-cause deaths, recurrent athero-thrombotic events, all cause hospitalizations, specific causes of death and hospitalizations) during the 12 follow-up of each enrolment phase.
Time frame: 12 months
Showing the first 100 of 196 sites. Choose a country and city above to see the rest.
Started Sep 2023 (actual). Primary completion is estimated for Jun 2026, 33 months after the start.
Of 165 non-industry observational studies under Myocardial Ischemia, half reached primary completion within 51 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 127. This study's planned 33 months is below that.
Counting every sponsor, half of 204 studies reached it within 40 months; a quarter within 21 and three quarters within 90.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heart Care Foundation